Serotonin signaling is associated with lower amyloid-  levels and plaques in transgenic mice and humans

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Opposing Synaptic Regulation of Amyloid-  Metabolism by NMDA Receptors In Vivo

(2011) D. K. Verges et al.   JOURNAL OF NEUROSCIENCE

5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment

(2011) Fei Shen et al.   NEUROPHARMACOLOGY

Deletion of M1 Muscarinic Acetylcholine Receptors Increases Amyloid Pathology In Vitro and In Vivo

(2010) A. A. Davis et al.   JOURNAL OF NEUROSCIENCE

Blowing hot and cold over depression and cognitive impairment

(2010) Y. E. Geda   NEUROLOGY

Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment

(2010) V. M. Dotson et al.   NEUROLOGY

Depressive symptoms and risk of dementia: The Framingham Heart Study

(2010) J. S. Saczynski et al.   NEUROLOGY

APOEpredicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

(2009) John C. Morris et al.   ANNALS OF NEUROLOGY

Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease

(2009) John C. Morris et al.   ARCHIVES OF NEUROLOGY

Antidepressants and dementia

(2009) Lars Vedel Kessing et al.   JOURNAL OF AFFECTIVE DISORDERS

Synaptic NMDA Receptor Activation Stimulates  -Secretase Amyloid Precursor Protein Processing and Inhibits Amyloid-  Production

(2009) S. E. Hoey et al.   JOURNAL OF NEUROSCIENCE

Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice

(2009) P. Yan et al.   JOURNAL OF NEUROSCIENCE

Will anti-amyloid therapies work for Alzheimer's disease?

(2008) Peter H St George-Hyslop et al.   LANCET

Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

(2008) Clive Holmes et al.   LANCET

History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease

(2008) M. I. Geerlings et al.   NEUROLOGY

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL